Implantation of Peripheral Stem Cells in Patient With Ischemic Cardiomyopathy

Inclusion Criteria: * Patients with ischemic cardiomyopaty and HF II-IV NYHA class * MI more than 6 months before the study * LVEF less than 35% * Absence effect of coronary revascularization during 6 months * Optimal pharmacological therapy no less than 8 weeks * Heart transplantation is contraindicated * Patients with implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) * Patients giving informed consent Exclusion Criteria: * Acute coronary syndrome * Coronary revascularization less than 6 months * Patients requiring surgical correction of post-MI aneurism * LV wall thickness less than 5 mm in site of possible injection * Patients with CRT implanted within 3 month before cells injection * Clinically significant associated diseases * Active oncology desiase * Pregnancy